Login to Your Account



Zogenix Eyes Public Markets, Files for Potential $86M IPO

By Jennifer Boggs


Tuesday, March 25, 2008
Only days after the FDA accepted for review Zogenix Inc.'s new drug application for its needle-free sumatriptan candidate, the San Diego-based firm filed for an initial public offering. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription